2024-04-02 19:00:11 ET
Image source: The Motley Fool.
Ocugen (NASDAQ: OCGN)
Q4 2023 Earnings Call
Apr 02, 2024 , 8:30 a.m. ET
Operator
For further details see:
Ocugen (OCGN) Q4 2023 Earnings Call Transcript2024-04-02 19:00:11 ET
Image source: The Motley Fool.
Ocugen (NASDAQ: OCGN)
Q4 2023 Earnings Call
Apr 02, 2024 , 8:30 a.m. ET
Operator
For further details see:
Ocugen (OCGN) Q4 2023 Earnings Call TranscriptMarket Wire News is a media platform, the information on this page was provided by Motley Fool via Quote Media. Read our full disclaimer.
When you linking your Twitter Account Market Wire News Trending Stocks news and your Portfolio Stocks News will automatically tweet from your Twitter account.
Be alerted of any news about your stocks and see what other stocks are trending.
News, Short Squeeze, Breakout and More Instantly...
Ocugen, Inc. Company Name:
OCGN Stock Symbol:
Market:
Established Medium Dose as Safe and Tolerable Dose in Current OCU410 Clinical Trial DSMB Recommends Continuing with High-Dose Cohort Dosing with Concurrent Phase 2 Dosing MALVERN, Pa., May 31, 2024 (GLOBE NEWSWIRE) -- Ocugen, Inc. (Ocugen or the Company) (NASDAQ: OCGN), a biotechn...
2024-05-29 12:53:53 ET Ocugen (NASDAQ: OCGN) stock price is doing well this year as investors focus on its ongoing drug trials and its milestones. It has soared by over 177% this year, outperforming the S&P 500, Nasdaq 100, and the iShars Biotechnology ETF (IBB), which has dropped b...
MALVERN, Pa., May 29, 2024 (GLOBE NEWSWIRE) -- Ocugen, Inc. (Ocugen or the Company) (NASDAQ:OCGN), a biotechnology company focused on discoverin...